LCIG

3 Pipeline Drugs That Could Have a Dramatic Impact on Parkinson's Disease by 2020
Motley Fool
Thu, 10/17/13 - 08:24 am
Parkinson's Disease
pimavanserin
Acadia
Duodopa
AbbVie
LCIG
AFQ056
Novartis